CUSIP No. 717123 10 3 Page 1 of 11 Pages
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________
SCHEDULE 13G
Information Statement pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 5)
Pharmaceutical Marketing Services Inc.
_________________________________________________________________
(Name of Issuer)
Common Stock, $.01 par value
_________________________________________________________________
(Title of Class of Securities)
717123 10 3
_________________________________________________________________
(CUSIP Number)
________________________
<PAGE>
CUSIP No. 717123 10 3 Page 2 of 11 Pages
_________________________________________________________________
1) Name of Reporting Person Welsh, Carson,
S.S. or I.R.S. Identification Anderson & Stowe V,
No. of Above Person L.P.
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place Delaware
of Organization
_________________________________________________________________
Number of 5) Sole Voting 746,215 shares of Shares
Beneficially Power Common Stock, $.01
Owned by Each par value ("Common
Reporting Person Stock")
With: ________________________________________
6) Shared Voting 1,041,144 shares of
Power Common Stock
_______________________________________
7) Sole Disposi- 746,215 shares of
tive Power Common Stock
________________________________________
8) Shared Dis- 1,041,144 shares of
positive Power Common Stock
________________________________________
9) Aggregate Amount Beneficially 746,215 shares of
Owned by Each Reporting Person Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9) [X]
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 5.7%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
<PAGE>
CUSIP No. 717123 10 3 Page 3 of 11 Pages
_________________________________________________________________
1) Name of Reporting Person Welsh, Carson,
S.S. or I.R.S. Identification Anderson &
No. of Above Person Stowe IV
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place New York
of Organization
_________________________________________________________________
Number of 5) Sole Voting 571,558 shares of
Shares Beneficially Power Common Stock
Owned by Each
Reporting Person ________________________________________
With: 6) Shared Voting 1,041,144 shares of
Power Common Stock
________________________________________
7) Sole Disposi- 571,558 shares of
tive Power Common Stock
________________________________________
8) Shared Dis- 1,041,144 shares of
positive Power Common Stock
________________________________________
9) Aggregate Amount Beneficially 571,558 shares of
Owned by Each Reporting Person Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9) [X]
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 4.3%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
<PAGE>
CUSIP No. 717123 10 3 Page 4 of 11 Pages
_________________________________________________________________
1) Name of Reporting Person WCAS Capital
S.S. or I.R.S. Identification Partners, L.P.
No. of Above Person
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place Delaware
of Organization
_________________________________________________________________
Number of Shares 5) Sole Voting 179,881 shares
Beneficially Power of Common Stock
Owned by Each
Reporting Person
With: ________________________________________
6) Shared Voting 1,041,144 shares
Power of Common Stock
________________________________________
7) Sole Disposi- 179,881 shares
tive Power of Common Stock
_______________________________________
8) Shared Dis- 1,041,144 shares
positive Power of Common Stock
________________________________________
9) Aggregate Amount Beneficially 179,881 shares
Owned by Each Reporting Person of Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9) [X]
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 1.4%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
_________________________________________________________________
1) Name of Reporting Person WCAS Venture
S.S. or I.R.S. Identification Partners
No. of Above Person
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
CUSIP No. 717123 10 3 Page 5 of 11 Pages
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place New York
of Organization
_________________________________________________________________
Number of Shares 5) Sole Voting 9,986 shares
Beneficially Power of Common Stock
Owned by Each
Reporting Person
With: ________________________________________
6) Shared Voting 1,041,144 shares
Power of Common Stock
________________________________________
7) Sole Disposi- 9,986 shares
tive Power of Common Stock
_______________________________________
8) Shared Dis- 1,041,144 shares
positive Power of Common Stock
________________________________________
9) Aggregate Amount Beneficially 9,986 shares
Owned by Each Reporting Person of Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9) [X]
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 0.1%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
<PAGE>
CUSIP No. 717123 10 3 Page 6 of 11 Pages
Amendment No. 5 to Schedule 13G
Reference is hereby made to the statement on Schedule
13G originally filed with the Securities and Exchange Commission
on February 4, 1992, as amended by Amendment No. 1 thereto filed
on February 10, 1994, Amendment No. 2 thereto filed on May 11,
1994, Amendment No. 3 thereto filed on March 17, 1995 and
Amendment No. 4 thereto filed on January 31, 1996.
Item 1(a) - Name of Issuer: Pharmaceutical Marketing Services
Inc.
Item 1(b) - Address of Issuer's Principal Executive Offices:
2394 East Camelback Road
Phoenix, AZ 85016
Item 2(a) - Name of Person Filing:
This statement is being filed by Welsh, Carson,
Anderson & Stowe V, L.P., a Delaware limited
partnership ("WCAS V"), Welsh, Carson, Anderson &
Stowe IV, a New York limited partnership ("WCAS
IV"), WCAS Capital Partners, L.P., a Delaware
limited partnership ("Capital Partners"), and WCAS
Venture Partners, a New York limited partnership
("Venture Partners") (collectively, the "Reporting
Persons").
Item 2(b) - Address of Principal Business Office:
320 Park Avenue, Suite 2500
New York, New York 10022
Item 2(c) - Place of Organization:
WCAS V: Delaware
WCAS IV: New York
Capital Partners: Delaware
Venture Partners: New York
Item 2(d) - Title of Class of Securities:
Common Stock, $.01 par value ("Common Stock")
Item 2(e) - CUSIP Number: 717123 10 3
<PAGE>
CUSIP No. 717123 10 3 Page 7 of 11 Pages
Item 3 - Statements Filed Pursuant to Rules 13d-1(b) or
13d-2(b):
Not applicable.y
Item 4 - Ownership.
(a) Amount Beneficially Owned:
WCAS V: 746,215 shares of Common Stock
WCAS IV: 571,558 shares of Common Stock
Capital Partners: 179,881 shares of Common Stock
Venture Partners: 9,986 shares of Common Stock
(b) Percent of Class:
WCAS V: 5.7%
WCAS IV: 4.3%
Capital Partners: 1.4%
Venture Partners: 0.1%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
WCAS V: 746,215 shares of Common Stock
WCAS IV: 571,558 shares of Common Stock
Capital Partners: 179,881 shares of Common Stock
Venture Partners: 9,986 shares of Common Stock
(ii) shared power to vote or to direct the vote:
WCAS V: 1,041,144 shares of
Common Stock
WCAS IV: 1,041,144 shares of Common Stock
Capital Partners: 1,041,144 shares of Common
Stock
Venture Partners: 1,041,144 shares of Common
Stock
(iii) sole power to dispose or to direct the
disposition of:
WCAS V: 746,215 shares of Common Stock
WCAS IV: 571,558 shares of Common Stock
Capital Partners: 179,881 shares of Common Stock
Venture Partners: 9,986 shares of Common Stock
<PAGE>
CUSIP No. 717123 10 3 Page 8 of 11 Pages
(iv) shared power to dispose or to direct the
disposition of:
WCAS V: 1,041,144 shares of Common Stock
WCAS IV: 1,041,144 shares of Common Stock
Capital Partners: 1,041,144 shares of Common
Stock
Venture Partners: 1,041,144 shares of Common
Stock
The 1,041,144 shares of Common Stock with respect
to which the Reporting Persons may be deemed to share the power
to vote or direct the vote and to dispose or direct the
disposition of represent the aggregate number of shares held by
Source Informatics Inc. ("SII") and SI PMSI Ltd., a wholly-owned
subsidiary of SII. Such shares were previously held by Walsh
International Holdings Ltd., a wholly-owned subsidiary of Walsh
International Inc. ("Walsh"), but were transferred to SII in
connection with the reorganization of Walsh. The Reporting
Persons as a group own approximately 37% of SII. Each of the
Reporting Persons disclaims beneficial ownership of any
securities, and any proceeds thereof, that are not actually
distributed to it.
Item 5 - Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6 - Ownership of More than Five Percent on Behalf of
Another Person:
Not applicable.
Item 7 - Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on By the Parent Company:
Not applicable.
Item 8 - Identification and Classification of Members of
the Group:
See Exhibit 2.
Item 9 - Notice of Dissolution of Group:
Not applicable.
Item 10 - Certification:
Not applicable.
<PAGE>
CUSIP No. 717123 10 3 Page 9 of 11 Pages
Signature:
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
WELSH, CARSON, ANDERSON & STOWE V, L.P.
By: WCAS V Partners, General Partner
Byy /s/ Laura VanBuren
General Partner
WELSH, CARSON, ANDERSON & STOWE IV
By: WCAS IV Partners, General Partner
Byy /s/ Russell L. Carson
General Partner
WCAS CAPITAL PARTNERS, L.P.
By: WCAS CP Partners, General Partner
Byy /s/ Russell L. Carson
General Partner
WCAS VENTURE PARTNERS
By: WCAS Ventures, General Partner
Byy /s/ Laura VanBuren
General Partner
Dated: January 21, 1997
<PAGE>
CUSIP No. 717123 10 3 Page 10 of 11 Pages
EXHIBIT 1
AGREEMENT
OF
WELSH, CARSON, ANDERSON & STOWE V, L.P.
WELSH, CARSON, ANDERSON & STOWE IV
WCAS CAPITAL PARTNERS, L.P.
AND
WCAS VENTURE PARTNERS
yPURSUANT TO RULE 13d-1(f)
The undersigned hereby agree that the Information Statement
on Schedule 13G to which this Agreement is annexed as Exhibit 1 is
filed on behalf of each of them in accordance with the provisions of
Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended.
WELSH, CARSON, ANDERSON & STOWE V, L.P.
By: WCAS V Partners, General Partner
Byy /s/ Laura VanBuren
General Partner
WELSH, CARSON, ANDERSON & STOWE IV
By: WCAS IV Partners, General Partner
Byy /s/ Russell L. Carson
General Partner
WCAS CAPITAL PARTNERS, L.P.
By: WCAS CP Partners, General Partner
Byy /s/ Russell L. Carson
General Partner
WCAS VENTURE PARTNERS
By: WCAS Ventures, General Partner
Byy /s/ Laura VanBuren
General Partner
Dated: January 21, 1997
<PAGE>
CUSIP No. 717123 10 3 Page 11 of 11 Pages
EXHIBIT 2
Identification and Classification
of Members of the Group
_________________________________
Welsh, Carson, Anderson & Stowe V, L.P., Welsh, Carson,
Anderson & Stowe IV, WCAS Capital Partners, L.P. and WCAS Venture
Partners are filing this statement on Schedule 13G as a group.
Welsh, Carson, Anderson & Stowe V, L.P. is a Delaware limited
partnership. Its sole general partner is WCAS V Partners, a New Jersey
general partnership.
Welsh, Carson, Anderson & Stowe IV is a New York limited
partnership. Its sole general partner is WCAS IV Partners, a New York
general partnership.
WCAS Capital Partners, L.P. is a Delaware limited
partnership. Its sole general partner is WCAS CP Partners, a New York
general partnership.
WCAS Venture Partners is a New York limited partnership. Its
sole general partner is WCAS Ventures, a New York general partnership.
